Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009

Treatment of Low-Risk Gestational Trophoblastic Neoplasia

(2011) Carol Aghajanian   JOURNAL OF CLINICAL ONCOLOGY

The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1

(2010) S McGrath et al.   BRITISH JOURNAL OF CANCER

Weekly methotrexate (50mg/m2) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia

(2010) Woo Dae Kang et al.   GYNECOLOGIC ONCOLOGY

Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia

(2010) Arb-aroon Lertkhachonsuk et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Gestational trophoblastic disease

(2010) Michael J Seckl et al.   LANCET

Gestational Trophoblastic Neoplasia

(2010) Anna V. Hoekstra et al.   OBSTETRICS AND GYNECOLOGY

Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity

(2009) Gihad Elias Chalouhi et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia

(2009) L.M. El-Helw et al.   GYNECOLOGIC ONCOLOGY

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)

(2008) J. Wang et al.   ANNALS OF ONCOLOGY